Tenax Therapeutics (TENX) Income towards Parent Company: 2010-2016
Historic Income towards Parent Company for Tenax Therapeutics (TENX) over the last 3 years, with Dec 2016 value amounting to -$34.3 million.
- Tenax Therapeutics' Income towards Parent Company fell 183.07% to -$34.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$56.6 million, marking a year-over-year increase of 57.81%. This contributed to the annual value of -$17.6 million for FY2024, which is 126.43% down from last year.
- As of Q4 2016, Tenax Therapeutics' Income towards Parent Company stood at -$34.3 million, which was down 661.27% from -$4.5 million recorded in Q3 2016.
- Over the past 5 years, Tenax Therapeutics' Income towards Parent Company peaked at -$1.6 million during Q4 2012, and registered a low of -$118.0 million during Q2 2013.
- Moreover, its 2-year median value for Income towards Parent Company was -$8.9 million (2015), whereas its average is -$14.1 million.
- Data for Tenax Therapeutics' Income towards Parent Company shows a peak YoY increase of 66.56% (in 2013) and a maximum YoY decrease of 4,393.38% (in 2013) over the last 5 years.
- Tenax Therapeutics' Income towards Parent Company (Quarterly) stood at -$1.6 million in 2012, then tumbled by 4,393.38% to -$118.0 million in 2013, then reached -$12.1 million in 2015, then plummeted by 183.07% to -$34.3 million in 2016.
- Its Income towards Parent Company was -$34.3 million in Q4 2016, compared to -$4.5 million in Q3 2016 and -$5.7 million in Q2 2016.